HNF1 beta (HNF1B) Human shRNA Plasmid Kit (Locus ID 6928)
CAT#: TG308907
HNF1B - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | HNF1 beta (HNF1B) Human shRNA Plasmid Kit (Locus ID 6928) |
Locus ID | 6928 |
UniProt ID | P35680 |
Synonyms | ADTKD3; FJHN; HNF-1-beta; HNF-1B; HNF1beta; HNF2; HPC11; LF-B3; LFB3; MODY5; RCAD; T2D; TCF-2; TCF2; VHNF1 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | HNF1B - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 6928). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_000458, NM_001165923, NM_001304286, NM_006481, NM_000458.1, NM_000458.2, NM_000458.3, NM_001165923.1, NM_001165923.2, NM_001165923.3, NM_006481.1, BC017714, BC017714.1, NM_000458.4, NM_001165923.4 |
Summary | This gene encodes a member of the homeodomain-containing superfamily of transcription factors. The protein binds to DNA as either a homodimer, or a heterodimer with the related protein hepatocyte nuclear factor 1-alpha. The gene has been shown to function in nephron development, and regulates development of the embryonic pancreas. Mutations in this gene result in renal cysts and diabetes syndrome and noninsulin-dependent diabetes mellitus, and expression of this gene is altered in some types of cancer. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Inhibition of Cell Death and Induction of G2 Arrest Accumulation in Human Ovarian Clear Cells by HNF-1ß Transcription Factor: Chemosensitivity Is Regulated by Checkpoint Kinase CHK1
,Shigetomi, H;Sudo, T;Shimada, K;Uekuri, C;Tsuji, Y;Kanayama, S;Naruse, K;Yamada, Y;Konishi, N;Kobayashi, H;,
Int. J. Gynecol. Cancer
,PubMed ID 24804869
[HNF1B]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...